To confirm that AKT phosphorylation contributes to the biological function of miR-1468 in HCC cells, we used AKT inhibitor MK2206 or AKT activator IGF-1 (insulin-like growth factor 1) to alter AKT activation. This evidence concerns the gene AKT1 and hepatocellular carcinoma.